Metabonomic characterization of the 3-nitropropionic acid rat model of huntington's disease

Neurochemical Research

Volumn 34, Issue 7, 2009, Pages 1261-1271

  Tsang, T M ^a   Haselden, J N ^b   Holmes, E ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Amino butyric acid (GABA); 3 Nitropropionic acid (3 NP); Choline; Huntington's disease (HD); Magic angle spinning (MAS); Metabonomics; Mitochondria; N Acetylaspartate (NAA); N Acetylaspartylglutamate (NAAG); NMR spectroscopy; Succinate

Indexed keywords

3 NITROPROPIONIC ACID; 4 AMINOBUTYRIC ACID; GLYCEROL; PHOSPHATIDYLCHOLINE; SUCCINATE DEHYDROGENASE; SUCCINIC ACID; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; EXPERIMENTAL MODEL; FRONTAL CORTEX; GLOBUS PALLIDUS; HUNTINGTON CHOREA; MALE; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN STEM; CEREBELLUM; CEREBRAL CORTEX; CHOLINE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; HUNTINGTON DISEASE; LACTIC ACID; MALE; METABOLOMICS; NITRO COMPOUNDS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHORYLCHOLINE; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; SUCCINIC ACID; TAURINE;

RATTUS;

EID: 67349196013     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9904-5     Document Type: Article

References (64)

1. GJ Harris GD Pearlson CE Peyser 1992 Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease Ann Neurol 31 69 75 10.1002/ana.410310113
2. RH Myers J Leavitt LA Farrer 1989 Homozygote for Huntington disease Am J Hum Genet 45 615 618 (Pubitemid 19261450)
3. 1H NMR spectroscopy J Proteome Res 5 483 492 10.1021/pr050244o
4. DL Gustine 1979 Aliphatic nitrocompounds in crownvetch Crop Sci 19 197 203
5. Wilson BJ (1971) Miscellaneous Aspergillus toxins. In: Ciegler A, Kadis S, Ajl SJ (eds) Microbial toxins, vol 6. Academic Press, New York, pp 251-257
6. DH Gould DL Gustine 1982 Basal ganglia degeneration, myelin alterations, and enzyme inhibition induced in mice by the plant toxin 3-nitropropanoic acid Neuropathol Appl Neurobiol 8 377 393 10.1111/j.1365-2990.1982.tb00306.x (Pubitemid 13199709)
7. AC Ludolph M Seelig AG Ludolph 1992 ATP deficits and neuronal degeneration induced by 3-nitropropionic acid Ann N Y Acad Sci 648 300 302 10.1111/j.1749-6632.1992.tb24562.x
8. AC Ludolph F He PS Spencer 1991 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin Can J Neurol Sci 18 492 498
9. F He S Zhang F Qian 1995 Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid) Neurology 45 2178 2183 (Pubitemid 27100244)
10. DH Gould MP Wilson DW Hamar 1985 Brain enzyme and clinical alterations induced in rats and mice by nitroaliphatic toxicants Toxicol Lett 27 83 89 10.1016/0378-4274(85)90123-7
11. E Brouillet MC Guyot V Mittoux 1998 Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat J Neurochem 70 794 805 (Pubitemid 28079371)
12. MC Guyot P Hantraye R Dolan 1997 Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid Neuroscience 79 45 56 10.1016/S0306-4522(96) 00602-1
13. M Riepe A Ludolph M Seelig 1994 Increase of ATP levels by glutamate antagonists is unrelated to neuroprotection NeuroReport 5 2130 2132 10.1097/00001756-199410270-00035 (Pubitemid 24340087)
14. EM Urbanska P Blaszczak T Saran 1999 AMPA/kainate-related mechanisms contribute to convulsant and proconvulsant effects of 3-nitropropionic acid Eur J Pharmacol 370 251 256 10.1016/S0014-2999(99)00147-8
15. WT Lee YZ Shen C Chang 2000 Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy Neuroscience 95 89 95 10.1016/S0306-4522(99)00410-8
16. MF Beal E Brouillet BG Jenkins 1993 Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid J Neurosci 13 4181 4192 (Pubitemid 23299942)
17. GW Kim JC Copin M Kawase 2000 Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid J Cereb Blood Flow Metab 20 119 129 10.1097/00004647- 200001000-00016 (Pubitemid 30019837)
18. Andrew ER, Eades RG (1959) Removal of dipolar broadening of NMR spectra of solids by spectral rotation. Nature 183:1802. doi: 10.1038/1831802a0
19. LL Cheng CL Lean A Bogdanova 1996 Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning Magn Reson Med 36 653 658 10.1002/mrm.1910360502
20. KK Millis WE Maas DG Cory 1997 Gradient, high-resolution, magic-angle spinning nuclear magnetic resonance spectroscopy of human adipocyte tissue Magn Reson Med 38 399 403 10.1002/mrm.1910380307
21. NJ Waters S Garrod RD Farrant 2000 High-resolution magic angle spinning (1)H NMR spectroscopy of intact liver and kidney: optimization of sample preparation procedures and biochemical stability of tissue during spectral acquisition Anal Biochem 282 16 23 10.1006/abio.2000.4574
22. LL Cheng IW Chang BL Smith 1998 Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy J Magn Reson 135 194 202 10.1006/jmre.1998.1578 (Pubitemid 128450704)
23. E Humpfer M Spraul AW Nicholls 1997 Direct observation of resolved intracellular and extracellular water signals in intact human red blood cells using 1H MAS NMR spectroscopy Magn Reson Med 38 334 336 10.1002/mrm.1910380224
24. TM Tsang JL Griffin J Haselden 2005 Metabolic characterization of distinct neuroanatomical regions in rats by magic angle spinning 1H nuclear magnetic resonance spectroscopy Magn Reson Med 53 1018 1024 10.1002/mrm.20447
25. Montgomerie H (1980) In: Drury RAB, Wallington EA (eds) Carleton's histological technique, 5 edn. Oxford University Press, Oxford
26. Bancroft JD, Stevens A (1982) In: Bancroft JD, Stevens A (eds) Theory and practice of histological techniques. Churchill Livingstone, Edinburgh
27. PJ Foxall JK Nicholson 1998 Nuclear magnetic resonance spectroscopy: a non-invasive probe of kidney metabolism and function Exp Nephrol 6 409 414 10.1159/000020549 (Pubitemid 28439328)
28. NJ Waters E Holmes CJ Waterfield 2002 NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha- naphthylisothiocyanate Biochem Pharmacol 64 67 77 10.1016/S0006-2952(02)01016-X
29. J Henke W Willker J Engelmann 1996 Combined extraction techniques of tumour cells and lipid/phospholipid assignment by two dimensional NMR spectroscopy Anticancer Res 16 1417 1427 (Pubitemid 26257811)
30. Wold S, Johannsson E, Cocchi M (1993) 3D-QSAR in drug design, theory, methods, and applications. ESCOM Science
31. Hoskuldsson A (1996) Prediction methods in science and technology. Thor Publishing, Copenhagen
32. Wold S, Albano C, Dunn WJ et al (1984) In: Kowalski BR (ed) Mutlivariate data analysis in chemistry. D. Reidel Publishing Company, Dordrecht
33. MH Baslow 2000 Functions of N-acetyl-l-aspartate and N-acetyl-l- aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling J Neurochem 75 453 459 10.1046/j.1471-4159.2000.0750453.x
34. BF Hamilton DH Gould 1987 Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage Acta Neuropathol 72 286 297 10.1007/BF00691103
35. BF Hamilton DH Gould 1987 Correlation of morphologic brain lesions with physiologic alterations and blood-brain barrier impairment in 3-nitropropionic acid toxicity in rats Acta Neuropathol 74 67 74 10.1007/BF00688340
36. JC Vis MM Verbeek RM De Waal 1999 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum Neuropathol Appl Neurobiol 25 513 521 10.1046/j.1365-2990.1999.00212.x
37. C Dautry F Vaufrey E Brouillet 2000 Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid J Cereb Blood Flow Metab 20 789 799 10.1097/00004647-200005000-00005 (Pubitemid 30317053)
38. WR Martin M Wieler CC Hanstock 2007 Is brain lactate increased in Huntington's disease? J Neurol Sci 263 70 74 10.1016/j.jns.2007.05.035
39. Z Binienda DL Frederick SA Ferguson 1995 The effects of perinatal hypoxia on the behavioral, neurochemical, and neurohistological toxicity of the metabolic inhibitor 3-nitropropionic acid Metab Brain Dis 10 269 282 10.1007/BF02109358
40. I Mader W Roser L Kappos 2000 Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study AJNR Am J Neuroradiol 21 1220 1227 (Pubitemid 30655655)
41. PM De Stefano NMatthews DL Arnold 1995 Reversible decreases in N-acetylaspartate after acute brain injury Magn Reson Med 34 721 727 10.1002/mrm.1910340511
42. TE Bates M Strangward J Keelan 1996 Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo NeuroReport 7 1397 1400 10.1097/00001756-199605310-00014 (Pubitemid 26281000)
43. VJ Montpetit F Andermann S Carpenter 1971 Subacute necrotizing encephalomyelopathy A review and a study of two families Brain 94 1 30 10.1093/brain/94.1.1
44. EJ Novotny Jr G Singh DC Wallace 1986 Leber's disease and dystonia: a mitochondrial disease Neurology 36 1053 1060 (Pubitemid 16038581)
45. B Hassel U Sonnewald 1995 Selective inhibition of the tricarboxylic acid cycle of GABAergic neurons with 3-nitropropionic acid in vivo J Neurochem 65 1184 1191
46. EG McGeer PL McGeer 1976 Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids Nature 263 517 519 10.1038/263517a0
47. MF Beal 1994 Neurochemistry and toxin models in Huntington's disease Curr Opin Neurol 7 542 547 10.1097/00019052-199412000-00012
48. PV Cicchetti FGould A Parent 1996 Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's disease Brain Res 730 232 237 (Pubitemid 26305345)
49. EM Urbanska P Blaszczak T Saran 1998 Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice Eur J Pharmacol 359 55 58 10.1016/S0014-2999(98) 00648-7
50. E Brouillet F Conde MF Beal 1999 Replicating Huntington's disease phenotype in experimental animals Prog Neurobiol 59 427 468 10.1016/S0301- 0082(99)00005-2
51. A Schurr MT Tseng CA West 1987 Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study Life Sci 40 2059 2066 10.1016/0024-3205(87)90098-1
52. A Lehmann H Hagberg B Nystrom 1985 In vivo regulation of extracellular taurine and other neuroactive amino acids in the rabbit hippocampus Prog Clin Biol Res 179 289 311
53. RO Law 1998 The role of taurine in the regulation of brain cell volume in chronically hyponatraemic rats Neurochem Int 33 467 472 10.1016/S0197-0186(98) 00051-5
54. RF Butterworth 1996 Taurine in hepatic encephalopathy Adv Exp Med Biol 403 601 606 (Pubitemid 26365243)
55. R Sanchez-Olea C Pena J Moran 1993 Inhibition of volume regulation and efflux of osmoregulatory amino acids by blockers of Cl- transport in cultured astrocytes Neurosci Lett 156 141 144 10.1016/0304-3940(93)90458-W (Pubitemid 23214743)
56. BK Puri 2006 Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia Int Rev Psychiatry 18 145 147 10.1080/09540260600581852
57. 1H NMR spectroscopy Neurology 43 2689 2695 (Pubitemid 24004570)
58. M Anthony MLZhao KM Brindle 1999 Inhibition of phosphatidylcholine biosynthesis following induction of apoptosis in HL-60 cells J Biol Chem 274 19686 19692 10.1074/jbc.274.28.19686
59. FG Blankenberg PD Katsikis RW Storrs 1997 Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy Blood 89 3778 3786 (Pubitemid 27227102)
60. FG Blankenberg RW Storrs L Naumovski 1996 Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy Blood 87 1951 1956 (Pubitemid 26068910)
61. DM Dunlop DSMc Hale A Lajtha 1992 Decreased brain N-acetylaspartate in Huntington's disease Brain Res 580 44 48 10.1016/0006-8993(92)90925-Y
62. WE Klunk K Panchalingam J Moossy 1992 N-Acetyl-l-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study Neurology 42 1578 1585
63. DJ Meyerhoff S MacKay L Bachman 1993 Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging Neurology 43 509 515 (Pubitemid 23088483)
64. T Ebisu WD Rooney SH Graham 1994 N-Acetylaspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus: 1H magnetic resonance spectroscopic imaging J Cereb Blood Flow Metab 14 373 382 (Pubitemid 24129471)